Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,252.00 -28.34 (-2.21%)
Streaming Delayed Price Updated: 2:29 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
If You Invested $1000 In Eli Lilly Stock 5 Years Ago, You Would Have This Much Today ↗
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 25.47% on an annualized basis producing an average annual return of 37.22%. Currently, Eli Lilly has a market capitalization of... 
Via Benzinga
News headline image
Why Vivosim Labs Shares Are Rocketing on Wednesday? ↗
VivoSim Labs shares climbed after receiving a $5 million Eli Lilly milestone payment and forecasting more than 500% revenue growth in FY2027. 
Via Benzinga
News headline image
3 Vanguard ETFs Poised to Outperform as the Market Shifts Beyond Big Tech ↗
With investors finally embracing market segments beyond technology, these three Vanguard ETFs are winning. 
Via The Motley Fool
Topics ETFs
News headline image
2 Beaten-Down GLP-1 Stocks to Buy on the Dip ↗
Don't wait until clinical milestones send their share prices soaring. 
Via The Motley Fool
Eli Lilly & Co. (NYSE:LLY) Passes Navellier’s High-Growth Screen on Strong Earnings and Sales Momentum ↗
Via Chartmill
News headline image
Can Biogen Score Another Win In Alzheimer's Disease? ↗
Biogen and Ionis said Tuesday their tau-targeting Alzheimer's treatment slowed cognitive decline by 26% over 18 months. 
Via Investor's Business Daily
News headline image
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market? ↗
Eyes are on the rollout of Lilly's new weight loss pill. 
Via The Motley Fool
News headline image
Cathie Wood Bought $54 Million Worth Of SpaceX Stock Last Week ↗
Cathie Wood's ARK Invest was extremely active last week, adding SpaceX and Meta, while selling AMD and Robinhood stock. 
Via Investor's Business Daily
Topics ETFs
News headline image
Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst Upgrades ↗
Eli Lilly shares are in the spotlight Monday as the company presents new Kisunla data at the AAIC in London. 
Via Benzinga
News headline image
Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors ↗
Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue. 
Via The Motley Fool
News headline image
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? ↗
IBBQ surged 54.5% in one year but carries deeper drawdowns. XLV offers broader diversification, lower costs, and double dividend yield for steadier returns. 
Via The Motley Fool
Topics ETFs
News headline image
Which is the Better Choice for Healthcare Investors? IYH or BBH? ↗
BBH delivered 33.6% returns but swung 39.9% lower; IYH's 100 holdings offer steadier performance with 1.2% dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It? ↗
One small investment offers big benefits for Nvidia. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026 ↗
This is the list for you if you are looking for dividend stocks with attractive yields and well-supported dividends. 
Via The Motley Fool
News headline image
Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗
There are good reasons to invest in Lilly and to hold off. 
Via The Motley Fool
News headline image
History Says Doing This 1 Thing Will Score You an Investing Win -- Even After a Market Crash. ↗
It's something very simple. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? ↗
So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes off. 
Via The Motley Fool
News headline image
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? ↗
Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over the past five years. 
Via The Motley Fool
Topics ETFs
News headline image
Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock. ↗
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating. 
Via The Motley Fool
News headline image
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗
PJP delivers lower volatility and higher income with concentrated pharma exposure, while XBI offers broader biotech growth at lower cost. 
Via The Motley Fool
Topics ETFs
News headline image
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up? ↗
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential. 
Via The Motley Fool
Topics ETFs
News headline image
1 Unpopular Stock That Should Get More Attention and 2 That Underwhelm
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
My Forever Portfolio: 5 Undervalued Stocks to Buy Now and Hold Forever ↗
Investing for the long-term requires a different strategy. 
Via The Motley Fool
News headline image
Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? ↗
PJP delivered stronger 5-year returns with lower volatility, while FBT offers broader biotech exposure at a slightly cheaper cost. 
Via The Motley Fool
Topics ETFs
News headline image
Is It Too Late to Buy Eli Lilly? ↗
The stock has soared 400% in recent years. 
Via The Motley Fool
News headline image
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger ↗
As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities. 
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
Stocks making big moves yesterday: Carlisle, Rivian, Blink Charging, Genpact, and Eli Lilly
Check out the companies making headlines yesterday: Carlisle (NYSE:CSL): Building envelope solutions provider Carlisle Companies (NYSE:CSL) fell by 4.2% on T... 
Via StockStory
Topics Economy Electric Vehicles
News headline image
Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026 ↗
Eli Lilly's next leg of growth may have less to do with how well its weight loss drugs work and more to do with how many people can finally get them. 
Via The Motley Fool
News headline image
Why Eli Lilly Stock Climbed to a Record High Today ↗
Wall Street is getting more bullish on the pharma giant's shares. 
Via The Motley Fool
News headline image
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom ↗
Don't sleep on these medical device leaders. 
Via The Motley Fool
Topics Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.